🇺🇸 FDA
Patent

US 9089698

Method and apparatus for optogenetic treatment of blindness including retinitis pigmentosa

granted A61KA61K38/177A61K9/0048

Quick answer

US patent 9089698 (Method and apparatus for optogenetic treatment of blindness including retinitis pigmentosa) held by The Regents of the University of California expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/177, A61K9/0048